Another mechanism occurs upon the interaction of the programmed cell death 1 (PD1) molecule and its ligand programmed cell death ligand 1 (PDL1), often expressed by tumor cells, which inhibits the antitumor activity of PD1+ Teff lymphocytes (4). This evidence concerns the gene CD274 and neoplasm.